Global Central Nervous System Drugs Market Research Report 2016

October 2016 | 115 pages | ID: G8FE03C079AEN
S&P Consulting

Abstracts

The Global Central Nervous System Drugs Market Research Report 2016 is a valuable source of insightful data for business strategists.

It provides the Central Nervous System Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Central Nervous System Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Central Nervous System Drugs Market: Regional Segment Analysis

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

The Major players reported in the market include:

• Johnson & Johnson
• Pfizer
• Novartis
• Roche
• Sanofi-Aventis
• Merck
• GSK
• Bayer Schering
• Bristol-Myers Squibb
• AbbVie
• Eli Lilly
• AstraZeneca
• Takeda
• Actavis
• Astellas Pharma US
• Teva
• Biogen
• Shire

Global Central Nervous System Drugs Market: Product Segment Analysis

• Type I
• Type II
• Type III

Global Central Nervous System Drugs Market: Application Segment Analysis

• Application I
• Application II
• Application III

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified SWOT analysis of major market segments

Contents

CHAPTER 1 CENTRAL NERVOUS SYSTEM DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Central Nervous System Drugs
1.2 Central Nervous System Drugs Market Segmentation by Type
  1.2.1 Global Production Market Share of Central Nervous System Drugs by Type in 2015
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Central Nervous System Drugs Market Segmentation by Application
  1.3.1 Central Nervous System Drugs Consumption Market Share by Application in 2015
  1.3.2 Application I
  1.3.3 Application II
  1.3.4 Application III
1.4 Central Nervous System Drugs Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Central Nervous System Drugs (2011-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON CENTRAL NERVOUS SYSTEM DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
2.3 Effects to Central Nervous System Drugs Industry

CHAPTER 3 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 Global Central Nervous System Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 Global Central Nervous System Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Central Nervous System Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Central Nervous System Drugs Manufacturing Base Distribution, Sales Area and Product Type
3.5 Central Nervous System Drugs Market Competitive Situation and Trends
  3.5.1 Central Nervous System Drugs Market Concentration Rate
  3.5.2 Central Nervous System Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

4.1 Global Central Nervous System Drugs Production by Region (2011-2016)
4.2 Global Central Nervous System Drugs Production Market Share by Region (2011-2016)
4.3 Global Central Nervous System Drugs Revenue (Value) and Market Share by Region (2011-2016)
4.4 Global Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016)
4.5 North America Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016)
4.6 Europe Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016)
4.7 China Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016)
4.8 Japan Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016)
4.9 Southeast Asia Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016)
4.10 India Central Nervous System Drugs Production, Revenue, Price and Gross Margin (2011-2016)

CHAPTER 5 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

5.1 Global Central Nervous System Drugs Consumption by Regions (2011-2016)
5.2 North America Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016)
5.3 Europe Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016)
5.4 China Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016)
5.5 Japan Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016)
5.6 Southeast Asia Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016)
5.7 India Central Nervous System Drugs Production, Consumption, Export, Import by Regions (2011-2016)

CHAPTER 6 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Central Nervous System Drugs Production and Market Share by Type (2011-2016)
6.2 Global Central Nervous System Drugs Revenue and Market Share by Type (2011-2016)
6.3 Global Central Nervous System Drugs Price by Type (2011-2016)
6.4 Global Central Nervous System Drugs Production Growth by Type (2011-2016)

CHAPTER 7 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS MARKET ANALYSIS BY APPLICATION

7.1 Global Central Nervous System Drugs Consumption and Market Share by Application (2011-2016)
7.2 Global Central Nervous System Drugs Consumption Growth Rate by Application (2011-2016)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS MANUFACTURERS ANALYSIS

8.1 Johnson & Johnson
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.1.4 Business Overview
8.2 Pfizer
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.2.4 Business Overview
8.3 Novartis
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.3.4 Business Overview
8.4 Roche
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.4.4 Business Overview
8.5 Sanofi-Aventis
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.5.4 Business Overview
8.6 Merck
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.6.4 Business Overview
8.7 GSK
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.7.4 Business Overview
8.8 Bayer Schering
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.8.4 Business Overview
8.9 Bristol-Myers Squibb
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.9.4 Business Overview
8.10 AbbVie
  8.10.1 Company Basic Information, Manufacturing Base and Competitors
  8.10.2 Product Type, Application and Specification
  8.10.3 Sales, Revenue, Price and Gross Margin (2011-2016)
  8.10.4 Business Overview
8.11 Eli Lilly
8.12 AstraZeneca
8.13 Takeda
8.14 Actavis
8.15 Astellas Pharma US
8.16 Teva
8.17 Biogen
8.18 Shire

…

CHAPTER 9 CENTRAL NERVOUS SYSTEM DRUGS MANUFACTURING COST ANALYSIS

9.1 Central Nervous System Drugs Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Central Nervous System Drugs

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Central Nervous System Drugs Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 ANALYSIS OF INVESTMENT STRATEGY

11.1 Industry Development Characters
  11.1.1 Periodicity of the industry
  11.1.2 Regional traits of the industry
  11.1.3 Upstream and downstream of Central Nervous System Drugs industry
  11.1.4 Operational mode of the industry
11.2 Analysis of Investment Situation of Central Nervous System Drugs Industry
  11.2.1 Development Pattern
  11.2.2 Entry Barrier
  11.2.3 Industrial SWOT Analysis
  11.2.4 Analysis of Industrial Five Forces Mode
11.3 Analysis of Development Trend

CHAPTER 12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

CHAPTER 13 MARKET EFFECT FACTORS ALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

CHAPTER 14 GLOBAL CENTRAL NERVOUS SYSTEM DRUGS MARKET FORECAST (2016-2021)

14.1 Global Central Nervous System Drugs Production, Revenue Forecast (2016-2021)
14.2 Global Central Nervous System Drugs Production, Consumption Forecast by Regions (2016-2021)
14.3 Global Central Nervous System Drugs Production Forecast by Type (2016-2021)
14.4 Global Central Nervous System Drugs Consumption Forecast by Application (2016-2021)
14.5 Central Nervous System Drugs Price Forecast (2016-2021)

CHAPTER 15 RESEARCH FINDINGS AND CONCLUSION

CHAPTER 16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Figures
Figure Picture of Central Nervous System Drugs
Figure Global Production Market Share of Central Nervous System Drugs by Type in 2015
Figure Application of Central Nervous System Drugs
Figure North America Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Central Nervous System Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Central Nervous System Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Figure Global Central Nervous System Drugs Capacity of Key Manufacturers in 2015
Figure Global Central Nervous System Drugs Capacity of Key Manufacturers in 2016
Figure 2015 Central Nervous System Drugs Production Share by Manufacturers
Figure 2016 Central Nervous System Drugs Production Share by Manufacturers
Figure Global Market Central Nervous System Drugs Average Price of Key Manufacturers in 2015
Figure Central Nervous System Drugs Market Share of Top 3 Manufacturers
Figure Central Nervous System Drugs Market Share of Top 5 Manufacturers
Figure Global Central Nervous System Drugs Capacity Market Share by Regions (2011-2016)
Figure Global Central Nervous System Drugs Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Central Nervous System Drugs Capacity Market Share by Regions
Figure Global Central Nervous System Drugs Production and Market Share by Regions (2011-2016)
Figure Global Central Nervous System Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Central Nervous System Drugs Production Market Share by Regions
Figure Global Central Nervous System Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Central Nervous System Drugs Consumption Market Share by Regions
Figure Production Market Share of Central Nervous System Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Central Nervous System Drugs by Type
Figure Production Revenue Share of Central Nervous System Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Central Nervous System Drugs by Type
Figure Global Central Nervous System Drugs Production Growth by Type (2011-2016)
Figure Global Central Nervous System Drugs Consumption Market Share by Application in 2015
Figure Global Central Nervous System Drugs Consumption Growth Rate by Application (2011-2016)
List of Tables
Table Product Overview and Scope of Central Nervous System Drugs
Table Major Manufacturers of Type I
Table Major Manufacturers of Type II
Table Major Manufacturers of Type III
Table Central Nervous System Drugs Consumption Market Share by Application in 2015
Table Global Central Nervous System Drugs Capacity of Key Manufacturers (2015 and 2016)
Table Global Central Nervous System Drugs Capacity Market Share by Manufacturers (2015 and 2016)
Table Global Central Nervous System Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Central Nervous System Drugs Production Share by Manufacturers (2015 and 2016)
Table Global Central Nervous System Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Central Nervous System Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Central Nervous System Drugs Revenue Share by Manufacturers
Table 2016 Global Central Nervous System Drugs Revenue Share by Manufacturers
Table Global Market Central Nervous System Drugs Average Price of Key Manufacturers (2015 and 2016)
Table Manufacturers Central Nervous System Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Central Nervous System Drugs Product Type
Table Global Central Nervous System Drugs Capacity by Regions (2011-2016)
Table Global Central Nervous System Drugs Production by Regions (2011-2016)
Table Global Central Nervous System Drugs Revenue by Regions (2011-2016)
Table Global Central Nervous System Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Central Nervous System Drugs Revenue Market Share by Regions
Table Global Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table India Central Nervous System Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Central Nervous System Drugs Consumption Market by Regions (2011-2016)
Table Global Central Nervous System Drugs Consumption Market Share by Regions (2011-2016)
Table North America Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016)
Table China Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016)
Table India Central Nervous System Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Central Nervous System Drugs Production by Type (2011-2016)
Table Global Central Nervous System Drugs Production Share by Type (2011-2016)
Table Global Central Nervous System Drugs Revenue by Type (2011-2016)
Table Global Central Nervous System Drugs Revenue Share by Type (2011-2016)
Table Global Central Nervous System Drugs Price by Type (2011-2016)
Table Global Central Nervous System Drugs Consumption by Application (2011-2016)
Table Global Central Nervous System Drugs Consumption Market Share by Application (2011-2016)
Table Global Central Nervous System Drugs Consumption Growth Rate by Application (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Central Nervous System Drugs Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Central Nervous System Drugs Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Central Nervous System Drugs Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Central Nervous System Drugs Global Market Share (2011-2016)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Aventis Central Nervous System Drugs Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Central Nervous System Drugs Global Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Central Nervous System Drugs Global Market Share (2011-2016)
Table Bayer Schering Basic Information List
Table Bayer Schering Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Schering Central Nervous System Drugs Global Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Central Nervous System Drugs Global Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Central Nervous System Drugs Global Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Central Nervous System Drugs Global Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Central Nervous System Drugs Global Market Share (2011-2016)
Table Takeda Basic Information List
Table Takeda Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Central Nervous System Drugs Global Market Share (2011-2016)
Table Actavis Basic Information List
Table Actavis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actavis Central Nervous System Drugs Global Market Share (2011-2016)
Table Astellas Pharma US Basic Information List
Table Astellas Pharma US Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Pharma US Central Nervous System Drugs Global Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Central Nervous System Drugs Global Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Central Nervous System Drugs Global Market Share (2011-2016)
Table Shire Basic Information List
Table Shire Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Shire Central Nervous System Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Table Key Suppliers of Raw Materials
Table Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015
Table Major Buyers of Central Nervous System Drugs
Table Distributors/Traders List
Table Four basic brand strategies
Table Industrial SWOT Analysis
Table Global Central Nervous System Drugs Production Forecast by Regions (2016-2021)
Table Global Central Nervous System Drugs Consumption Forecast by Regions (2016-2021)
Table Global Central Nervous System Drugs Production Forecast by Type (2016-2021)
Table Global Central Nervous System Drugs Consumption Forecast by Application (2016-2021)